chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cold sweats; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Cold sweats) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COLD SWEAT (Cold sweats) and NAUSEA (Nauseous). At the time of the report, COLD SWEAT (Cold sweats) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Severe rash covering entire back and sides and inside of right arm. Itchy and painful. Not fluid filled.
TWO DOSES WERE GIVEN TO ONE PATIENT.  ONE DOSE IN EACH ARM.
At the patient's second dose appointment, he reported that after the first dose his left lymph node near his armpit on his vaccination arm became swollen about 1 day after receiving the vaccine.  It remained swollen for about 3 days, then resolved.  He said his arm felt tight below the lymph node, as well, which also resolved.
After the shot I developed swollen kidneys, Hydronephrosis. It feels like someone has put a catheter and ripped it out. It is extremely uncomfortable. My stomach is extremely bloated.. I have so much stool in my intestines that my digestive system is extremely slow, almost frozen. My throat has spams now. I have gone to my primary care and gastroenterologist and neither of them know exactly is causing this. I have had numerous tests done over the last year. I am still dealing with it today.
9pm, developed hard chills, aches, severe HA, took 1000 mg Tylenol, but 11:30 temp up to 102, severe HA, weakness, unable to sit up. ended up in the ER, negative COVID test, additional tylenol and IM injection  of Toradol.  DC home.   Temp max 102, HR max 130, still with HA and body aches today but no fever.
I had chicken pox / shingles shot almost killed me / nearly died; This serious case was reported by a consumer via interactive digital media and described the occurrence of chickenpox in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced chickenpox (Verbatim: I had chicken pox / shingles shot almost killed me / nearly died) (serious criteria hospitalization and life threatening). The outcome of the chickenpox was not reported.   It was unknown if the reporter considered the chickenpox to be related to Shingles vaccine.   It was unknown if the company considered the chickenpox to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 11-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that the shingles shot almost killed him/her.  The patient had chicken pox as an adult and nearly died, spent 11 days in the hospital. The reporter further stated that everyone wanted him/her to take the shingles shot and it was the worst thing he/she ever did. The follow up would not possible as no contact details were available.
Only reporting to VAERS as patient received covid-19 vaccination under EUA and was hospitalized and is now deceased from illness deemed UNRELATED to prior covid-19 vaccination.  She was a 69 yr old female who was transferred to hospital on 6/8  at 0141 from outside hospital with severe shock, acute hypoxemic respiratory failure, who had a cardiac arrest on arrival here for 5 mins, during arrest CPR was done and 2 doses of epinephrine were administered prior to ROSC and targeted temperature management was initiated. She was found to have a massive PE, alteplase was given and a heparin continuous infusion was started on 6/8 at 0154 and 0345, respectively. She later underwent a thrombectomy on 6/8 at 1640. She showed signs of poor neurological status. Went into MSOF despite aggressive supportive care. Family requested to make her comfortable and the patient expired on 6/10 at 0449.
reconstituted with unapproved diluent, administered; reconstituted with unapproved diluent, administered; This case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number 2NT5L, expiry date 12th May 2023) for prophylaxis.   On 4th March 2022, the patient received Shingrix. On 4th March 2022, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter stated that they reconstituted the Shingrix Lyophilized powder with an unapproved diluent then inadvertently administered to the patient in the right deltoid, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter wanted to know, how long did the patient had to wait to get the correct dosage. The reporter did not consent to follow-up.
Awakened next day (9/13) with extreme fatigue. I was very weak. Slept most of the day. Little or no appetite. Muscle aches in my back, thighs and shoulders. However I did not have a fever and did not feel otherwise ill - similar to influenza symptoms. Today (9/14) I feel much better - still tired but much less so.
Received high dose on Monday 10/30 and woke up Tuesday 10/31 with itching from top of head to toes "no rash". Encouraged her to see family physician.
Patient vaccinated with PCV-13 and flu 1-8-16, developed fever body aches and nausea that night.
HAVING NUMBNESS AND TINGLING TO EXTREMETIES AND FROM BREAST DOWN TRUNK.  HAD SOLUMEDROL 500 MG IV X 1 WITH ONLY MINIMAL RELIEF OF SYMPTOMS.  WILL SEE MY NURSE PRACTITIONER TODAY AND REQUESTING REFERRAL TO NEUROLOGY
20 minutes after receiving the 2nd dose of the Pfizer vaccine patient's face started itching. This was followed by lip tingling. Next the patient reported swelling of her face, tongue, and neck. Patient was taken to the emergency room and treated with IV steroids. Swelling and itching had subsided after being treated in the ER. Patient still reported a sensation as if a feather was rubbing against her face but since subsided a few days after being discharged.
Chills; Elevated fever for herself at 99.4-99.8F; 11 weeks pregnant; Felt achy; Sore arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (11 weeks pregnant), VACCINATION SITE PAIN (Sore arm), PYREXIA (Elevated fever for herself at 99.4-99.8F), CHILLS (Chills) and MYALGIA (Felt achy) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.  On 25-Jan-2021 at 9:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 16-Aug-2021. On 25-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (11 weeks pregnant), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Elevated fever for herself at 99.4-99.8F). On an unknown date, the patient experienced CHILLS (Chills) and MYALGIA (Felt achy). On 25-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (11 weeks pregnant) had resolved. At the time of the report, VACCINATION SITE PAIN (Sore arm), PYREXIA (Elevated fever for herself at 99.4-99.8F), CHILLS (Chills) and MYALGIA (Felt achy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 99.4 °F (abnormal) elevated fever for herself at 99.4-99.8F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was 11 weeks of pregnant at time of vaccination. Concomitant product was not provided. Treatment medication was not reported.
This case was reported by a other health professional via sales rep and described the occurrence of fever in a 6-month-old female patient who received PEDIARIX for prophylaxis. On an unknown date, the patient received PEDIARIX at an unknown dose. On an unknown date, less than a year after receiving PEDIARIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to PEDIARIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received PEDIARIX and other 6-month vaccines. It was unknown if the reporter considered the fever to be related to other 6-month vaccines. The reporter agreed to be follow up.
Administration error. This patient received 2 doses of Moderna (1/4/21 and 2/3/21). He had a reaction to the vaccine that his doctor determined he should only receive Janssen as a booster dose. He then received that booster dose on 11/18/21. Based on the recommendation of his rheumatologist and allergist, who deemed him immunocompromised due to the inflammatory condition he developed as a result of the moderna vaccines, he came in to the pharmacy and requested an additional booster dose of the Janssen vaccine. This does not follow the current CDC guidelines and therefore should not have been administered. The pharmacist who administered the vaccine was unaware that the Janseen vaccine does not qualify as a third dose in the primary covid vaccination series for an immunocompromised individual. She was also unaware that the CDC recommendation for a 3rd primary dose of mRNA vaccine applies to patients who are immunocompromised at the time of vaccination, which this patient was not. The patient reports no adverse effects as a result of the extra vaccination.
Fever (100.8), severe chills (convulsions), headache, diarrhea  Currently 31 weeks pregnant.
7 days p/vax, T up to 102 relieved by Tylenol 25JAN91, sz 26JAN91 seen in ER. Extremely low red count, seen by MD 28JAN91.  Red count low-bone marrow shutdown. Result viral infect 2-3 mos ago.
It was between 5-7 days after my second dose, the bizarre symptoms began. My taste and smell changed (and no, I did not have Covid-19). It started with onions, then went to garlic, eggs, peanut butter, coffee... this rancid, sweet smell of rotting meat. It is something that's very hard to describe as I have never experienced this smell before in my life. It would keep me awake at night, I could smell it across the room and even different levels of the house, my sense of smell was so enhanced it was absolutely abnormal. The top of my head tingled, as did the back of my neck, and my tongue constantly felt like pop rocks were on my tongue. As this progressed, I had two days where I could hardly get out of bed. My insides, every organ, was just terribly sore and cramped. I had bloodwork done and the technician could hardly take blood because my vein kept collapsing. She also commented I must have been dehydrated because she couldn't understand why my blood was so thick and dark looking. I've had bloodwork taken before, and this was very unusual. I never need OJ or food after giving blood, I bounce back right away, but this time it took me 4 days to feel somewhat human again. It was at this point a friend jokingly said they were testing to see if I was magnetic and I WAS. Not a fridge magnet, but a paperclip. It was in my clavicle and uterus, I could track it. The detox happened through my skin, I got these hard lumps in the back of my neck, skin tags on my stomach, and some other crazy things I'm not even sure how to explain. The toxic aspects of this vaccine does detox through the skin, as people around me who had not been vaccinated, became sick. This needs to be taken seriously. Either the lot I was given was contaminated with graphene, OR the vaccine contains graphene and my body did not have a favorable response.
About 9pm I got up off the couch and was dizzy. Thought I was dehydrated so I drank bottle of water. More dizzy at 11pm. Slowly laid down and slept til 6am. Woke up still dizzy - dissipated thru the day and was no longer dizzy by 5-6pm.
19JUN91 pt called 2 1/2 hrs p/receiving inject rt upper thigh-baby extremely fussy, leg swollen, area hot to touch; Knot at sight of inject; Improved greatly following day to normal;
herpes zoster; Information has been received from a lawyer regarding a case in litigation referring to a patient (pt) of unknown age and gender. Information about concurrent condition, medical history and concomitant medication was not reported. On an unknown date, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration date and route unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After receiving the vaccine, pt suffered herpes zoster. As a result of these symptoms, pt was seen and treated by medical providers and was still under their care. As a direct and proximate result of the defective vaccine, pt's symptoms had resulted in physical limitations not present prior to using Merck's product. Pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), pt sustained severe and permanent personal injuries. Further, as a tragic consequence of Merck's wrongful conduct, pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of pt's conduct, pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was not recovered. The causality assessment was considered as related by the lawyer.  The lawyer considered the event herpes zoster to be disability.
pt recv 1dose of varivax 11/2/95 & in 4/98 pt devel breakthrough varicella. health care profess felt pt exp not related to the varivax.
Seizures; This case was reported by a consumer via interactive digital media and described the occurrence of seizure in a male patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, several days after receiving Flu vaccine, the patient experienced seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the seizure was unknown.   The reporter considered the seizure to be possibly related to Flu vaccine.     Additional Information: GSK Receipt Date: 05-JAN-2023 Reporter's Comment: The case was received from the patient's parent via interactive digital media. The patient had the flu shot and had seizures days after receiving it. Did the reporter think that the event might have been related to the Product/Device. Additional Supportive Information: The follow-up could not be possible as no contact details were available.
Dolor de cabeza, dolor articular, dolor muscular, ojos vidriosos, fatiga, cansancio, mareo.
Tested positive on a home COVID-19 test on October 18, 2022; Called Dr. and was told to take extra vitamins; Took COVID-19 test 8 days later and tested negative.
Per pt's father, the child quickly became hot, had temp of 102 F, Had difficulty breathing heart was racing and became dazed, "out -of it", Pt did not like lose consciousness. Ambulance was called and pt transported to hospital. Pt was breathing normally by the time they got to the hospital and appeared recovered once they saw the doctor a couple hours later, No treatment given.
1st shot in June 2018 but never got the 2nd.; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date in June 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 13-MAY-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The patient never got the second. The patient asked should he/she go ahead now and get the second shot, start the series over, or just leave well enough alone. Additional Supportive Information:  Till the time of reporting the patient did not receive 2nd dose of vaccine, which led to incomplete course of vaccination.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2022 at 10:02 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 14-Feb-2022 at 10:02 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 14-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Census Ethnicity of the patient was reported.  Concomitant medication of the patient was not reported.  Vaccine administration time was given as 10:02:09 . No treatment information was provided by the reporter.
Pain at onset and has increased each day. Site is swollen and red with pain going up through shoulder. Lost of mobility and strength in left arm.
This report was received from the pt and has not been verified by a physician or other healthcare professional. The pt reported that she had no adverse experience following receipt of her 1st injection of Engerix-B on an unknown date in 1995. One month later, also in 1995, the pt reportedly received her 2nd injection of Engerix-B. The pt reported that, approx. 1 month following the 2nd injection, her "stomach bothered (her) for at least 6 months". She also "began noticing muscle aches". The pt reported that she now has anemia, fibromyalgia and "possibly rheumatoid arthritis or lupus". She stated that she experienced "constant inflammation". She reported that she has seen a physician for these events; she did not specify the treatment of these events. She stated, "all of these symptoms may not be attributed to the Engerix-B vaccine, but most began shortly after the 2nd injection". She also reported that she received the 3rd injection of Engerix-B on an unspecified date. The unspecified stomach problem resolved after "at least 6 months". The outcome of the muscle aches was not specified. As of 10/22/01, the anemia, fibromyalgia, possible rheumatoid arthritis and possible lupus were reportedly ongoing. Possible lupus is considered "Medically Serious".
5 days after shot my left arm became red, itchy and hot with the red lesion (referred to as ?COVID Arm?, but now (4/20/21) my entire left arm is swollen, itchy, red and generally uncomfortable. I may need to see a doctor because the swelling is concerning.
This case was reported by a physician via sales rep and described the occurrence of palpitation in a 58-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than an hour after receiving SHINGRIX, the patient experienced palpitation and tingling. On an unknown date, the outcome of the palpitation and tingling were recovered/resolved. It was unknown if the reporter considered the palpitation and tingling to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had heart palpitations and tingling to face within hour of receiving dose.  The symptoms resolved within an hour and patient did not seek medical attention. The reporter wanted to know if the patient should get the 2nd dose but would call Medical Information for advice and more data. Medical Information number was provided.
Mother reported that the day after vaccination the girl woke up with a generalized rash, papular erythematous and itchy. Patient was treated with BENADRYL, CLARITIN and DECADRON.
Left deltoid at injection site, swelling, erythema, warm to touch, pain. Tx. BENADRYL 25mg 2 tabs Q6 hours for 48 hours. ALEVE 2 tablets BID up to one week.
Began to feel nauseous, vomited x 3 in space of 2 hours. Saw ER physician for meds which stopped emesis.
No additional AE; patient was administered an improperly stored vaccine; This spontaneous report was received from Other and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  On 02-JUN-2023, the patient was administered an improperly stored vaccine. HBP provided limited pertinent information. Permission was provided to contact the HCP. No additional AE/PQC reported.
Patient became dizzy and faint. She was moved to the floor, legs elevated. Given water and wet paper towels behind neck and on forehead. Recovered quickly (3-4 minutes) and was propped up with a pillow to rest and sip water. Rested around 25 minutes.
1-2-09 client received MENACTRA about 9:15 AM.  V/S given and reviewed side effects.  After getting home, client states having S.O.B. and tightness in chest.  Client with mother.  Instructed to be driven ASAP to ER at hospital and notify facility of results.  Called client at 1:10pm.  States symptoms resolved after lying down and that he did not go to ER.  Will call if further problems.
pt w/prev CA w/radiation treatment; MD indicated to start immun since off treatmnet since JUNE; resum w/prev schedule, include live virus vax; pt was given OPV/HIB pt started vomiting w/fever, rash on face 25MAR94;